Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05258409 · ClinicalTrials.gov registry record · NA
Evaluating Body Acceptance Programs for Young Men
A NA study of Eating Disorders and Eating Behavior, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
- 1
- Study location
NCT05258409: Completed NA study of Eating Disorders and Eating Behavior, sponsored by Auburn University.
NCT05258409 is a NA study of Eating Disorders and Eating Behavior that has completed, run by Auburn University. The registered enrollment target is 241 participants, below the 316-participant average among 37 other Eating Disorders trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05258409, a NA study of Eating Disorders and Eating Behavior, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
- 1
- Study location
Study Summary
While eating disorders in males are often overlooked, up to 7 million men in the United States will experience an eating disorder in their lifetime. Critically, men are less likely to seek treatment for an eating disorder compared to women. Therefore, prevention programs that target male-specific eating disorder risk factors prior to the development of an eating or appearance-related disorder are crucial in reducing eating disorders in this population. Preliminary work by our group established the initial efficacy of a novel program, the Body Project: More than Muscles (MTM) compared to assessment-only control. This study will replicate and extend this research by comparing MTM to a time and attention matched control used in previous eating disorder prevention work, media advocacy (MA).
Primary Outcome
The EPSI is a 45-item measure scored on a 5-point rating scale with scores ranging from 0 to 4 on individual questions. The EPSI measures eating pathology across eight dimensions with higher scores indicating greater eating pathology.
Conditions Studied
Interventions
- BEHAVIORAL Media Advocacy (MA)
- BEHAVIORAL More than Muscles (MTM)
Study Locations (1)
Alabama
- Auburn University - Auburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2022-08-16 |
| Est. Completion | 2025-01-27 |
| Phase | NA |
What the finished NCT05258409 record still lists
NCT05258409 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 316-participant average among 37 other Eating Disorders trials with a reported enrollment target (24% lower).
The record links to 8 conditions, with Eating Disorders appearing as the primary indexed condition, and to 2 interventions - of which Media Advocacy (MA) is the first listed.
NCT05258409 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05258409 about?
NCT05258409 is a clinical study titled "Evaluating Body Acceptance Programs for Young Men". While eating disorders in males are often overlooked, up to 7 million men in the United States will experience an eating disorder in their lifetime. Critically, men are less likely to seek treatment for an eating disorder compared to women. Therefore, prevention programs that target male-specific ea...
What is the current status of trial NCT05258409?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2022-08-16. Estimated completion is 2025-01-27.
What conditions does trial NCT05258409 study?
This clinical trial studies the following conditions: Eating Disorders, Eating Behavior, Body Image Disturbance, Eating Disorder Symptom, Dysmorphic Features.
What interventions are being tested in trial NCT05258409?
The interventions under investigation include: Media Advocacy (MA) (BEHAVIORAL), More than Muscles (MTM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05258409?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05258409 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05258409's enrollment target sits among peer trials
241 8th of 37 higher than 30 of 37 other Eating Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eating Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Diabetes Body Project 2
RECRUITING · NA
-
Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI